Efficacy of Ramosetron on Irritable Bowel Syndrome - like Symptoms in Patients with Inactive Inflammatory Bowel Disease - A Randomized, Double-blind, Placebo-Controlled Study -
Latest Information Update: 01 Apr 2019
At a glance
- Drugs Ramosetron (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 27 Mar 2019 Status changed from not yet recruiting to completed.
- 18 Mar 2019 Planned End Date changed from 3 Feb 2019 to 18 Mar 2019.
- 03 Feb 2019 According to UMIN, the date for closure to data entry is 2019/02/03.